/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

C

Cornedine J. de Gooijer

Dutch Cancer Society(NL)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

33

Papers

529

Citations

12

h-index

13

i10-index

Cornedine J. de Gooijer is an academic researcher from Dutch Cancer Society. The author has contributed to research in topics: Occupational and environmental lung diseases & Pleural and Pulmonary Diseases & Lung Cancer Treatments and Mutations. The author has an h-index of 12, co-authored 29 publications.

ORCID: 0000-0002-4447-0149

Research Topics

Occupational and environmental lung diseases Pleural and Pulmonary Diseases Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Papers by this author

works

Trastuzumab-Emtansine and Osimertinib Combination Therapy to Target HER2 Bypass Track Resistance in EGFR Mutation-Positive NSCLC

2023 · JTO Clinical and Research Reports · 21 citations

https://doi.org/10.1016/j.jtocrr.2023.100481

M. Jebbink Adrianus J. de Langen Kim Monkhorst Mirjam C. Boelens

Artificial intelligence-based diagnosis of asbestosis: analysis of a database with applicants for asbestosis state aid

2022 · European Radiology · 5 citations

https://doi.org/10.1007/s00330-022-09304-2

Kevin B. W. Groot Lipman Cornedine J. de Gooijer Thierry N. Boellaard Ferdinand van der Heijden

Follow-up after first-Line nivOlumab plus ipilimumab in patients with diffuse pleuRal mesotheliomA: a real-world Dutch cohort study—FLORA

2025 · ESMO Open · 5 citations

https://doi.org/10.1016/j.esmoop.2024.104123

Li-Anne H Douma Maaike M. Hofman Fenneke Zwierenga T M T Zondervan

Prospective validation of an artificial intelligence assessment in a cohort of applicants seeking financial compensation for asbestosis (PROSBEST)

2025 · European Radiology Experimental · 3 citations

https://doi.org/10.1186/s41747-025-00619-5

Illaa Smesseim Kevin B. W. Groot Lipman Stefano Trebeschi Martijn M. Stuiver

OA18.04 Pembrolizumab Plus Lenvatinib in Second-Line Pleural Mesothelioma Patients: A Single Arm Phase II Study (PEMMELA Cohort 2)

2024 · Journal of Thoracic Oncology · 1 citations

https://doi.org/10.1016/j.jtho.2024.09.088

Li-Anne H Douma V.v.d. Noort F. Lalezari J.F. de Vries

MA05.08 Follow-Up after First-Line Nivolumab Plus Ipilimumab in Patients with Pleural Mesothelioma: A Real-World Dutch Cohort Study (FLORA-Study)

2024 · Journal of Thoracic Oncology · 1 citations

https://doi.org/10.1016/j.jtho.2024.09.128

Li-Anne H Douma Maaike M. Hofman Fenneke Zwierenga Alessandra I. G. Buma

Research topics

topics

Occupational and environmental lung diseases

Pleural and Pulmonary Diseases

Lung Cancer Treatments and Mutations

Cancer Immunotherapy and Biomarkers

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Chat about Author

Papers

Chat

Click to start Chat